Stein S A, Witkop C, Hill S, Fallon M D, Viernstein L, Gucer G, McKeever P, Long D, Altman J, Miller N R, Teitelbaum S L, Schlesinger S
Neurology. 1983 Mar;33(3):267-77. doi: 10.1212/wnl.33.3.267.
We studied an American kinship with sclerosteosis, an autosomal-recessive disorder of bone remodeling and bone overgrowth of the calvaria, skull base, and tubular bones. Unlike osteopetrosis, which is attributed to abnormal immune and osteoclast function as well as bone resorption, sclerosteosis appears to be primarily a disorder of osteoblast (bone formation) hyperactivity. Related to cranial vascular and neural foraminal narrowing and reduced intracranial volume, affected patients with sclerosteosis demonstrate frequent seventh nerve palsy, progressive optic and cranial neuropathies, mixed hearing loss, brainstem compression, intracranial hypertension with increased elastance, and sudden, premature death. Management should involve early childhood identification of homozygotes, monitoring and aggressive treatment of intracranial hypertension, and extensive bone removal from skull, posterior fossa, and cervical spine.
我们研究了一种与硬化性骨病相关的美国家系,硬化性骨病是一种常染色体隐性疾病,表现为颅骨、颅底和管状骨的骨重塑异常及骨质过度生长。与骨硬化症不同,骨硬化症归因于异常的免疫和破骨细胞功能以及骨吸收,而硬化性骨病似乎主要是成骨细胞(骨形成)活动亢进的疾病。由于与颅血管和神经孔狭窄以及颅内体积减小有关,患有硬化性骨病的患者常出现第七神经麻痹、进行性视神经和颅神经病变、混合性听力丧失、脑干受压、颅内高压伴弹性增加,以及突然的过早死亡。治疗应包括在儿童早期识别纯合子、监测和积极治疗颅内高压,以及广泛切除颅骨、后颅窝和颈椎的骨质。